143 related articles for article (PubMed ID: 15204746)
1. Protection of rats against perfluoroisobutene (PFIB)-induced pulmonary edema by curosurf and N-acetylcysteine.
van Helden HP; van de Meent D; Oostdijk JP; Joosen MJ; van Esch JH; Hammer AH; Diemel RV
Inhal Toxicol; 2004 Jul; 16(8):549-64. PubMed ID: 15204746
[TBL] [Abstract][Full Text] [Related]
2. Asthmalike symptoms following intratracheal exposure of Guinea pigs to sulfur mustard aerosol: therapeutic efficacy of exogenous lung surfactant curosurf and salbutamol.
van Helden HP; Kuijpers WC; Diemel RV
Inhal Toxicol; 2004 Jul; 16(8):537-48. PubMed ID: 15204745
[TBL] [Abstract][Full Text] [Related]
3. [The protective effect of N-acetylcysteine on acute lung injury induced by PFIB inhalation].
Yang LM; Zhao J; Wang HT; Xu XX; JIiao YM; Ding RG
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2017 Jul; 35(7):481-486. PubMed ID: 29081093
[No Abstract] [Full Text] [Related]
4. The effect of perfluoroisobutene and phosgene on rat lavage fluid surfactant phospholipids.
Jugg B; Jenner J; Rice P
Hum Exp Toxicol; 1999 Nov; 18(11):659-68. PubMed ID: 10602390
[TBL] [Abstract][Full Text] [Related]
5. Oral N-acetylcysteine protects against perfluoroisobutene toxicity in rats.
Lailey AF
Hum Exp Toxicol; 1997 Apr; 16(4):212-6. PubMed ID: 9154446
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Curosurf in a rat model of acute respiratory distress syndrome.
van Helden HP; Kuijpers WC; Langerwerf PE; Langen RC; Haagsman HP; Bruijnzeel PL
Eur Respir J; 1998 Sep; 12(3):533-9. PubMed ID: 9762775
[TBL] [Abstract][Full Text] [Related]
7. Cell injuries of the blood-air barrier in acute lung injury caused by perfluoroisobutylene exposure.
Meng G; Zhao J; Wang HM; Ding RG; Zhang XC; Huang CQ; Ruan JX
J Occup Health; 2010; 52(1):48-57. PubMed ID: 20035103
[TBL] [Abstract][Full Text] [Related]
8. Acute head-only exposure of dogs to phosgene. Part III. Comparison of indicators of lung injury in dogs and rats.
Pauluhn J
Inhal Toxicol; 2006 Aug; 18(9):609-21. PubMed ID: 16864552
[TBL] [Abstract][Full Text] [Related]
9. Acute nose-only exposure of rats to phosgene. Part II. Concentration x time dependence of changes in bronchoalveolar lavage during a follow-up period of 3 months.
Pauluhn J
Inhal Toxicol; 2006 Aug; 18(9):595-607. PubMed ID: 16864551
[TBL] [Abstract][Full Text] [Related]
10. Exercise potentiation of lung injury following inhalation of a pneumoedematogenic gas: perfluoroisobutylene.
Lehnert BE; Archuleta D; Gurley LR; Session W; Behr MJ; Lehnert NM; Stavert DM
Exp Lung Res; 1995; 21(2):331-50. PubMed ID: 7774531
[TBL] [Abstract][Full Text] [Related]
11. Protection by cysteine esters against chemically induced pulmonary oedema.
Lailey AF; Hill L; Lawston IW; Stanton D; Upshall DG
Biochem Pharmacol; 1991 Dec; 42 Suppl():S47-54. PubMed ID: 1768285
[TBL] [Abstract][Full Text] [Related]
12. Suppression of perfluoroisobutylene induced acute lung injury by pretreatment with pyrrolidine dithiocarbamate.
Zhao J; Shao Z; Zhang X; Ding R; Xu J; Ruan J; Zhang X; Wang H; Sun X; Huang C
J Occup Health; 2007 Mar; 49(2):95-103. PubMed ID: 17429166
[TBL] [Abstract][Full Text] [Related]
13. Inhalation toxicity of 1,6-hexamethylene diisocyanate homopolymer (HDI-IC) aerosol: results of single inhalation exposure studies.
Pauluhn J
Toxicol Sci; 2000 Nov; 58(1):173-81. PubMed ID: 11053554
[TBL] [Abstract][Full Text] [Related]
14. The effect of hexafluorocyclobutene on rat bronchoalveolar lavage fluid surfactant phospholipids and alveolar type II cells.
Jugg B; Jenner J; Hughes JN; Rice P
Hum Exp Toxicol; 2001 May; 20(5):267-76. PubMed ID: 11476160
[TBL] [Abstract][Full Text] [Related]
15. The prophylactic and therapeutic effects of cholinolytics on perfluoroisobutylene inhalation induced acute lung injury.
Zhang T; Zhang X; Shao Z; Ding R; Yang S; Ruan J; Sun X; Xu J; Huang C; Hu Z; Zhang X
J Occup Health; 2005 Jul; 47(4):277-85. PubMed ID: 16096351
[TBL] [Abstract][Full Text] [Related]
16. Effects of furosemide, torasemide and controlled fluid intake on perfluoroisobutene induced lung oedema and mortality.
Onyefuru LC; Upshall DG; Rice P
Arzneimittelforschung; 1996 Mar; 46(3):283-7. PubMed ID: 8901150
[TBL] [Abstract][Full Text] [Related]
17. Effect of N-acetylcysteine treatment on NO2-impaired type II pneumocyte surfactant metabolism.
Müller B; Oske M; Hochscheid R; Seifart C; Barth PJ; Garn H; von Wichert P
Eur J Clin Invest; 2001 Feb; 31(2):179-88. PubMed ID: 11168458
[TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine advancement of surfactant therapy in experimental meconium aspiration syndrome: possible mechanisms.
Kopincová J; Mokrá D; Mikolka P; Kolomazník M; Čalkovská A
Physiol Res; 2014; 63(Suppl 4):S629-42. PubMed ID: 25669694
[TBL] [Abstract][Full Text] [Related]
19. Antiinflammatory Effect of N-Acetylcysteine Combined with Exogenous Surfactant in Meconium-Induced Lung Injury.
Mikolka P; Kopincova J; Mikusiakova LT; Kosutova P; Calkovska A; Mokra D
Adv Exp Med Biol; 2016; 934():63-75. PubMed ID: 27283193
[TBL] [Abstract][Full Text] [Related]
20. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.
Günther A; Siebert C; Schmidt R; Ziegler S; Grimminger F; Yabut M; Temmesfeld B; Walmrath D; Morr H; Seeger W
Am J Respir Crit Care Med; 1996 Jan; 153(1):176-84. PubMed ID: 8542113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
